Farnesyltransferase inhibitor FTI-277 prevents autocrine growth stimulation of neuroblastoma by BDNF

Journal of Cancer Research and Clinical Oncology

Volumn 129, Issue 4, 2003, Pages 227-233

  Girgert, Rainer ^a   Wittrock, Josefa ^b   Pfister, Sabine ^b   Schweizer, Paul ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Farnesyltransferase; N myc; Neuroblastoma; Neurotrophins; Ras proteins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INACTIVATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0038454932     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0418-x     Document Type: Article

References (23)

1. Barbacid M (1995) Neurotrophic factors and their receptors. Curr Opin Cell Biol 7:148-155
2. Barettino D, Pombo P, Espliguero G, Rodriguez-Pena A (1999) The mouse neurotrophin receptor trkB gene is transcribed from two different promoters. Biochim Biophys Acta 1446:24-34
3. Birren SJ, Lo L, Anderson DJ (1993) Sympathetic neuroblasts undergo a developmental switch in trophic dependence. Development 119:597-610
4. Black CT, Atkinson JB (1997) Neuroblastoma. Semin Pediatr Surg 6:2-10
5. Chirgwin JM, Przybyla AE, Mac Donald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299
6. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA (1989) Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 84:829-839
7. Gibbs JB, Kohl NE, Koblan KS, Omer CA, Sepp-Lorenzino L, Rosen N, Anthony NJ, Conner MW, deSolms SJ, Williams TM, Graham SL, Hartman GD, Oliff A (1996) Farnesyltransferase inhibitors and anti-Ras therapy. Breast Cancer Res Treat 38:75-83
8. Girgert R, Hohnecker A, Wittrock J, Schweizer P (1999) Inhibition of farnesyl-protein-transferase in neuroblastoma cells by α-hydroxyfarnesyl-phosphonate. Anticancer Res 19:2959-2962
9. Girgert R, Wittrock J, Schweizer P (2001) Basical science in pediatric surgery. Neuroblastoma:Inhibition of progression. Eur J Ped Surg 11:363-367
10. Girgert R, Janessa A, Schweizer P (2002) Activity of farnesyltransferase inhibitors against neuroblastoma cells depends on loss of adhesion. Onkologie 25[Suppl 4]:185
11. Karp JE, Kaufmann SH, Adjei AA, Lancet JE, Wright JJ, End DW (2001) Current status of clinical trials of farnesyltransferase inhibitors. Curr Opin Oncol 13:470-476
12. Klein R, Lamballe F, Bryant S, Barbacid M (1992) The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 8:947-956
13. Lebowitz PF, Prendergast GC (1998) Non-Ras targets of farnesyltransferase inhibitors: focus on Rho. Oncogene 17:1439-1445
14. Lerner EC, Zhang TT, Knowles DB, Qian Y, Hamilton AD, Sebti SM (1997) Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene 15:1283-1288
15. Marini P, MacLeod RAF, Treuner C, Bruchelt G, Böhm W, Wolburg H, Schweizer P, Girgert R (1999) SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation. Cancer Gen Cytogen 112:161-164
16. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M (1989) Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 9:24-33
17. Misawa A, Hosoi H, Arimoto A, Shikata T, Akioka S, Matsumura T, Houghton PJ, Sawada T (2000) N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res 60:64-69
18. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854
19. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14:759-767
20. Schwäble J, Wittrock J, Schweizer P, Girgert R (1998) Detection of rare target genes on Northern-Blots with cDNA probes labeled by RT-PCR and simultaneous Digoxigenin incorporation. Anal Biochem 262:77-79
21. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116
22. Shaikenov TE, Adekenov SM, Williams RM, Prashad N, Baker FL, Madden TL, Newman R (2001) Arglabin-DMA, a plant-derived sesquiterpene, inhibits farnesyltransferase. Oncol Rep 8:173-179
23. Sun J, Qian Y, Hamilton AD, Sebti SM (1998) Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene 16:1467-1473